Literature DB >> 3733853

The effect of ara-C on survival and proliferation of HeLa cells. A time-lapse cinematographic and light microscopic study.

A M Lengsfeld, B Maurer-Schultze.   

Abstract

The cytocidal and cytostatic effect of ara-C on HeLa cells was studied by cell counting and time-lapse cinematography. The effect of ara-C clearly depended on the dose and duration of the treatment. Continuous exposure to ara-C above a threshold dose of about 0.5 microgram/ml killed almost all cells within 2 days. Short-term incubation (3 h) with high doses (200 and 400 micrograms/ml) led to death of the cultures within 5 days. On the other hand short-term exposure to low ara-C doses (4 and 20 micrograms/ml) exhibited mainly a cytostatic with no substantial cytocidal effect. Time-lapse studies on the fate of HeLa cells have shown directly that cells lethally damaged by ara-C die out of interphase. The present results confirm the S phase specific effect of ara-C: lethally damaged cells had shorter survival times, if they were in S phase during short-term drug exposure or at the time of drug addition in the case of continuous incubation. Most important with respect to the therapeutic use of ara-C was the effect on the cycle time. Not only the cycle that included the short-term treatment but also the next cycle of those cells that survived the treatment was prolonged (from 19 h to 29 h). Furthermore, these prolonged cycle times varied considerably compared to those of untreated controls.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3733853     DOI: 10.1007/bf00389237

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  28 in total

1.  Growth and nucleic acid synthesis in synchronously dividing populations of HeLa cells.

Authors:  T TERASIMA; L J TOLMACH
Journal:  Exp Cell Res       Date:  1963-04       Impact factor: 3.905

2.  Properties of mitotic cells prepared by mechanically shaking monolayer cultures of Chinese hamster cells.

Authors:  R A Tobey; E C Anderson; D F Petersen
Journal:  J Cell Physiol       Date:  1967-08       Impact factor: 6.384

3.  Kinetics of effect of 1-beta-D-arabinofuranosylcytosine, its 5'-palmitoyl ester, 1-beta-D-arabinofuranosyluracil, and tritiated thymidine on the viability of cultured leukemia L1210 cells.

Authors:  L J Wilkoff; E A Dulmadge; H H Lloyd
Journal:  J Natl Cancer Inst       Date:  1972-03       Impact factor: 13.506

4.  In vivo synchrony of solid B16 melanoma by cytosine arabinoside, an inhibitor of DNA synthesis.

Authors:  M H Gibson; F D Bertalanffy
Journal:  J Natl Cancer Inst       Date:  1972-10       Impact factor: 13.506

5.  Studies in mouse L-cells on the incorporation of 1-beta-D-arabinofuranosylcytosine into DNA and on inhibition of DNA polymerase by 1-beta-D-arabinofuranosylcytosine 5'-triphosphate.

Authors:  F L Graham; G F Whitmore
Journal:  Cancer Res       Date:  1970-11       Impact factor: 12.701

6.  Correlation of cytotoxicity with total intracellular exposure to 9-beta-D-arabinofuranosyladenine 5'-triphosphate.

Authors:  D S Shewach; W Plunkett
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

7.  Uptake of cytosine arabinoside (Ara-C) by LSA lymphoma after irradiation in the stationary phase of growth.

Authors:  J A Young; Y Maruyama
Journal:  Radiology       Date:  1982-03       Impact factor: 11.105

8.  Cell kinetic studies of the cytostatic and cytocidal effect of 1-beta-D-arabinofuranosylcytosine on the L1210 ascites tumor.

Authors:  R Fietkau; H Friede; B Maurer-Schultze
Journal:  Cancer Res       Date:  1984-03       Impact factor: 12.701

9.  Effects of 1-beta-D-arabinofuranosylcytosine on chromosomes, depending upon the cell cycle stage at the time of exposure.

Authors:  R C Moore
Journal:  Mutat Res       Date:  1981-10       Impact factor: 2.433

10.  Drugs five years later: cytarabine.

Authors:  W B Kremer
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.